Form 4: EPLUS INC Director Bruce M Bowen Reports Acquisition of 291 Shares in Lieu of Cash Compensation
SEC Form 4
Director Bruce M Bowen reports acquiring 291 shares of EPLUS INC common stock on January 2, 2025, in lieu of cash compensation under the company's 2024 Non-Employee Director Long Term Incentive Plan.
Summary
- On January 2, 2025, Bruce M Bowen, a director of EPLUS INC, acquired 291 shares of common stock.
- The shares were issued as an alternative to cash compensation under the ePlus' 2024 Non-Employee Director Long Term Incentive Plan.
- Following the transaction, Bowen directly owns 2,035 shares.
- Bowen also indirectly owns 1,084 shares through the Elizabeth Dederich Bowen Trust, 12,526 shares through the Bruce Montague Bowen Trust, and 10,700 shares through Bowen Holdings LLC.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating a director's acquisition of shares as part of a compensation plan. It doesn't inherently suggest positive or negative implications for the company's performance.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it signals director confidence.
Key Dates
| Date | Description |
|---|---|
| 01/02/2025 | Date of transaction: Bruce M Bowen acquired 291 shares of EPLUS INC common stock. |
| 01/03/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.